Description
A potent S1P receptor antagonist (EC50s = 0.093, 0.44, 0.32, 0.34, and 0.32 nM for human, mouse, rat, dog, and monkey S1P1 receptors); selective for S1P1, S1P4, and S1P5 receptors (EC50 = 6.1, >10,000, >10,000, 147, and 24.4 nM for S1P1-5, respectively); decreases peripheral lymphocytes in mouse, rat, dog, and monkey (IC50s = 101, 51, 58, and 98 nM, respectively) when administered at a dose of 1 mg/kg, i.v.; delays or prevents the onset and severity of murine EAE at doses of 0.3, 1, or 3 mg/kg
Formal name: (3R)-7-[[4-cyclopentyl-3-(trifluoromethyl)phenyl]methoxy]-1,2,3,4-tetrahydro-cyclopent[b]indole-3-acetic acid
Synonyms: APD334
Molecular weight: 457.5
CAS: 1206123-37-6
Purity: ≥95%
Formulation: A crystalline solid
Product Type|Biochemicals|Receptor Pharmacology|Antagonists||Research Area|Immunology & Inflammation|Adaptive Immunity||Research Area|Immunology & Inflammation|Autoimmunity|Rheumatoid Arthritis||Research Area|Lipid Biochemistry|Sphingolipids||Research Area|Neuroscience